Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: An animal experiment

Surgical Endoscopy

Volumn 24, Issue 3, 2010, Pages 578-583

  Amin, Anwar Tawfik ^a,b   Shiraishi, Norio ^a   Ninomiya, Shigeo ^a   Tajima, Masaaki ^a   Inomata, Masafumi ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Laparotomy; MIF; NFjB; Pneumoperitoneum; TNF ; Tumor growth

Indexed keywords

CARBON DIOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LAPAROTOMY; MALE; MOUSE; NONHUMAN; PNEUMOPERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL STRESS; SURGICAL TECHNIQUE; TUMOR GROWTH;

EID: 77649186400     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0609-x     Document Type: Article

References (33)

1. Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL (1998) Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc 12:1035-1038
2. Bouvy ND, Marquet RL, Jeekel J, Bonjer HJ (1997) Laparoscopic surgery is associated with less tumor growth stimulation than conventional surgery: an experimental study. Br J Surg 84:358-361
3. Abramovitch R, Marikovsky M, Meir G, Neeman M (1999) Stimulation of tumor growth by wound-derived growth factors. Br J Cancer 79:1392-1398
4. Belizon A, Balik E, Feingold DL, Bessler M, Arnell TD, Forde KA, Horst PK, Jain S, Cekic V, Kirman I, Whelan RL (2006) Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg 244:792-798
5. Lundberg O, Kristoffersson A (2005) Reduction of abdominal wall blood flow by clamping or carbon dioxide insufflation increases tumor growth in the abdominal wall: an experimental study in rats. Surg Endosc 19:720-723
6. Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopyassisted Bilroth I gastrectomy. Surg Laparosc Endosc 2:146-148
7. Hiki N, Shimizu N, Yamaguchi H, Imamura K, Kubota K, Kaminishi M (2006) Manipulation of the small intestine as a cause of the increased inflammatory response after open compared with laparoscopic surgery. Br J Surg 93:195-204
8. Ure BM, Neiwold TA, Bax NM, Ham M, van der Zee DC, Essen GJ (2002) Peritoneal, systemic, and distant organ inflammatory responses are reduced by a laparoscopic approach and carbon dioxide vs air. Surg Endosc 16:836-842
9. Hayden M, Ghosh S (2004) Signaling to NF-kappa B. Genes Dev 18:2195-2224
10. Wyke SM, Tisdale MJ (2005) NFjB mediates proteolysisinducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 92:711-721
11. Ravi R, Bedi A (2004) NFjB in cancer: a friend turned foe. Drug Resist Update 7:53-67
12. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary derived cytokine that potentiates lethal endotoxeamia. Nature 365:756-759 (Pubitemid 23339882)
13. Calandra T, Bernhagen J, Mitchell R, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902 (Pubitemid 24155670)
14. Bucala R (2000) A most interesting factor. Nature 408:167-168
15. Mitchell R, Bucala R (2000) Tumor growth-promoting properties of MIF. Semin Cancer Biol 10:359-366
16. Hira E, Ono T, Dhar D, El assal ON, Hishikawa Y, Yamanoi A, Nagasue N (2005) Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer 103:588-598
17. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR (2005) Macrophages induce invasiveness of epithelial cancer cells via NFjB and JNK. J Immunol 175:1197-1205
18. Matsui Y, Inomata M, Tojigamori M, Sonoda K, Shiraishi N, Kitano S (2005) Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti HER2 antobody in a murine model. Int J Oncol 27:681-685
19. Suematsu T, Shiromizu A, Yamaguchi K, Shiraishi N, Adachi Y, Kitano S (1999) Convenient murine pneumoperitoneal model for the study of laparoscopic cancer surgery. Surg Laparosc Endosc Per 9:279-281
20. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 68:752-759
21. Kats R, Metz CN, Akoum A (2002) Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometrial lesions. J Clin Endocrinol Metab 87:883-889
22. Narita T, Taga T, Sugita K, Nakazawa S, Ohta S (2001) The autocrine loop of epidermal growth factor receptor-epidermal growth factor/transforming factor alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC 549. Jpn J Cancer Res 92:269-278
23. Matsui Y, Inomata M, Izumi K, Sonoda K, Shiraishi N, Kitano S (2004) Hyaluronic acid stimulates tumor-cell proliferation at wound sites. Gastrointest Endosc 60:539-543
24. Coffey JC, Wang JH, Bouchier-Hayes D, Cotter TG, Redmond HP (2006) The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg 243:250-256
25. Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Menard S (2003) Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 362:527-533 (Pubitemid 36980657)
26. Lee SW, Gleason N, Blanco I, Asi ZK, Whelan RL (2002) Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy vs insufflation. Surg Endosc 16:36-39
27. Qadri S, Wang JH, Coffey JC, Alam M, O'Donnell A, Aherne T, Redmond HP (2004) Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg 79:990-995
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
29. Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431:405-406
30. Balkwill F (2002) Tumor necrosis factor or tumor-promoting factor? Cytokine Growth Factor Rev 13:134-135
31. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-pyest E, Urieli Shoval S, Galun E, Ben Neriah Y (2004) NFjB function as a tumor promoter in inflammationassociated cancer. Nature 431:461-466
32. Jarnagin WR, Delman K, Kooby D, Mastorides S, Zager J, Brennan MF, Blumgart LH, Federoff H, Fong Y (2000) Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg 231:762-771
33. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH (1998) Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 228:347-354 (Pubitemid 30191697)